Abigail Washington

发表

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs

F. Slack, D. Tenen, D. Kufe, 2017, Leukemia.

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

R. Soiffer, R. Joyce, Shuli Li, 2016, Blood.

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

D. Neuberg, D. Kufe, D. DeAngelo, 2016, Science Translational Medicine.

MUC 1 Inhibition Leads to Decrease in PD-L 1 Levels via Up-Regulation of miRNAs

F. Slack, D. Kufe, E. Anastasiadou, 2016 .

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.

P. Pandolfi, D. Kufe, R. Joyce, 2017, Blood.

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

F. Slack, D. Kufe, E. Anastasiadou, 2019, British journal of haematology.

A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia

B. Ebert, K. Ballen, D. DeAngelo, 2018, American journal of hematology.

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

R. Clark, D. Kufe, T. Kupper, 2016, Molecular Cancer Therapeutics.

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma

A. Kruisbeek, J. Rosenblatt, D. Avigan, 2017, Journal of immunotherapy.